Follow on Google News News By Tag * Pain Relief * Pain relieving drugs * Analgesics * Drug Delivery Technologies * Biodelivery Sciences * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | “The painkillers market will reach $68.2 billion in 2014 according to new Visiongain report”By: Visiongain Moses Akintomide-Akinwamide, a senior pharmaceutical and medical technology market analyst at Visiongain comments: “The rising incidence and prevalence of pain episodes in the increasingly ageing global population is a factor contributing to the growth of the pain relieving drugs market. However, the side effect profiles of pain relieving drugs - such as the cardiac side effects which have been reported for Celebrex – means that stringent monitoring is required for some drugs during their use. Gastrointestinal side effects such as oesophageal, gastric and duodenal ulceration which is associated with many non-steroidal anti-inflammatory drugs (NSAIDS) may act as a restraint to growth in the market. The tolerance and dependence issues which are notoriously associated with opioid pain relieving drugs in particular may also act to hinder growth in the market over the next decade. However, the leading anti-arthritic biologics will continue to generate high revenues despite the expiry of some of their patents as the expected slow uptake of biosimilars means that these expiries will impact less on the sales of these biologics over the next decade.” The reforms in some sectors of the pain relieving drugs market, like narcotics, offer growth opportunities. “New reformulated tamper-resistant versions of top sellers such as Oxycontin and Opana ER are being developed and introduced into the market. These measures should allay the fears of physicians who have been reluctant to prescribe these drugs, especially in high doses”, Moses added. Visiongain’s 323 page report provides revenue forecasts to 2024 for the global pain relieving drugs market and its leading regional markets. The new study includes OTC (over-the counter) and Rx (prescription) The report also includes analysis of strengths, weaknesses, opportunities and threats to the market, an analysis of the social, technological, economical, and political factors that will influence the market, together with interviews with key opinion leaders in the industry sharing their views on current market trends and the unmet needs in the market. Pain Relieving Drugs Market Forecast 2014-2024: Future Prospects For Leading Companies adds to visiongain’s extensive range of analytical reports on industries and markets in healthcare. For sample pages and further information concerning the Visiongain report Pain Relieving Drugs Market Forecast 2014-2024 please visit https://www.visiongain.com/ For an executive summary please contact: Email: Sara Peerun on sara.peerun@ Tel: +44 (0) 20 7336 6100 Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@ About visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors. Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions. End
Account Phone Number Disclaimer Report Abuse
|
|